Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Lemoinne

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Clinical Liver Disease|June 13, 2019
Screening for esophageal varicesSara Lemoinne, Dominique Thabut
Clinics and Research in Hepatology and Gastroenterology|August 12, 2017
Gut microbial profile in primary biliary cholangitis: Towards bioindicatorsSara Lemoinne, Philippe Marteau
Current Opinion in Pharmacology|October 8, 2019
New and emerging anti-fibrotic therapeutics entering or already in clinical trials in chronic liver diseasesSara Lemoinne, Scott L Friedman
Clinics and Research in Hepatology and Gastroenterology|July 3, 2019
Gut microbiota in PSC : From association to possible causality. Commentary to "Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis" by Nakamoto et al., Nature Microbiology, January 2019Sara Lemoinne, Joao Sabino, Harry Sokol
Cell and Tissue Research|June 22, 2016
Portal myofibroblasts connect angiogenesis and fibrosis in liverSara Lemoinne, Dominique Thabut, Chantal Housset
Annals of Internal Medicine|April 16, 2014
Triple therapy for hepatitis C virus infection in patients receiving hemodialysisSara Lemoinne, Benoit Barrou, Dominique Thabut
Alimentary Pharmacology & Therapeutics|December 28, 2018
Letter: reduction in projected mortality or need for liver transplantation associated with bezafibrate add-on in primary biliary cholangitis with incomplete UDCA responseChristophe Corpechot, Olivier Chazouillères, Sara Lemoinne, et al.
Alimentary Pharmacology & Therapeutics|May 24, 2021
Letter: the use of magnetic resonance scores (Anali) for risk stratification in PSCSara Lemoinne, Nora Cazzagon, Olivier Chazouillères, et al.
Biochimica Et Biophysica Acta|March 9, 2013
Origins and functions of liver myofibroblastsSara Lemoinne, Axelle Cadoret, Haquima El Mourabit, et al.
Journal of Clinical Medicine|April 3, 2021
Role of Angiogenesis in the Pathogenesis of NAFLDLin Lei, Haquima Ei Mourabit, Chantal Housset, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Clinical Liver Disease|June 13, 2019
Screening for esophageal varicesSara Lemoinne, Dominique Thabut
Clinics and Research in Hepatology and Gastroenterology|August 12, 2017
Gut microbial profile in primary biliary cholangitis: Towards bioindicatorsSara Lemoinne, Philippe Marteau
Current Opinion in Pharmacology|October 8, 2019
New and emerging anti-fibrotic therapeutics entering or already in clinical trials in chronic liver diseasesSara Lemoinne, Scott L Friedman
Clinics and Research in Hepatology and Gastroenterology|July 3, 2019
Gut microbiota in PSC : From association to possible causality. Commentary to "Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis" by Nakamoto et al., Nature Microbiology, January 2019Sara Lemoinne, Joao Sabino, Harry Sokol
Cell and Tissue Research|June 22, 2016
Portal myofibroblasts connect angiogenesis and fibrosis in liverSara Lemoinne, Dominique Thabut, Chantal Housset
Annals of Internal Medicine|April 16, 2014
Triple therapy for hepatitis C virus infection in patients receiving hemodialysisSara Lemoinne, Benoit Barrou, Dominique Thabut
Alimentary Pharmacology & Therapeutics|December 28, 2018
Letter: reduction in projected mortality or need for liver transplantation associated with bezafibrate add-on in primary biliary cholangitis with incomplete UDCA responseChristophe Corpechot, Olivier Chazouillères, Sara Lemoinne, et al.
Alimentary Pharmacology & Therapeutics|May 24, 2021
Letter: the use of magnetic resonance scores (Anali) for risk stratification in PSCSara Lemoinne, Nora Cazzagon, Olivier Chazouillères, et al.
Biochimica Et Biophysica Acta|March 9, 2013
Origins and functions of liver myofibroblastsSara Lemoinne, Axelle Cadoret, Haquima El Mourabit, et al.
Journal of Clinical Medicine|April 3, 2021
Role of Angiogenesis in the Pathogenesis of NAFLDLin Lei, Haquima Ei Mourabit, Chantal Housset, et al.
Pageof 5